Rhythmia Medical Inc. won a $200,000 grant from the National Institutes of Health to help it develop its electronic catheter for use during cardiac ablation procedures, Mass High Tech reported.
The Burlington-based startup plans to use its Small Business Innovation Research grant to develop its electronic catheter, which is designed to map the heart and its electrical activity during catheter ablations, in which surgeons remove the damaged cardiac tissue that causes arrhythmia, or irregular heartbeats.
In the scheme of things, the N.I.H. money is small beer for Rhythmia. The company has raised $9 million from investors, co-CEO and co-founder Leon Amariglio told the newspaper.
